A method for mapping the linear epitopes targeted by the natural antibody response to Zika virus infection using a VLP platform technology
Virology, ISSN: 0042-6822, Vol: 579, Page: 101-110
2023
- 3Citations
- 13Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations3
- Citation Indexes3
- CrossRef3
- Captures13
- Readers13
- 13
- Mentions1
- News Mentions1
- 1
Most Recent News
Researchers from University of New Mexico Report on Findings in Zika Virus (A Method for Mapping the Linear Epitopes Targeted By the Natural Antibody Response To Zika Virus Infection Using a Vlp Platform Technology)
2023 MAR 09 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Daily -- Data detailed on Mosquito-Borne Diseases - Zika Virus have been
Article Description
Zika virus (ZIKV), a mosquito-borne pathogen, is associated with neurological complications in adults and congenital abnormalities in newborns. There are no vaccines or treatments for ZIKV infection. Understanding the specificity of natural antibody responses to ZIKV could help inform vaccine efforts. Here, we used a technology called Deep Sequence-Coupled Biopanning to map the targets of the human antibody responses to ZIKV infection. A bacteriophage virus-like particle (VLP) library displaying overlapping linear peptides derived from the ZIKV polyprotein was generated. The library was panned using IgG from 23 ZIKV-infected patients from Panama and deep sequencing identified common targets of anti-ZIKV antibodies within the ZIKV envelope glycoprotein. These included epitopes within the fusion loop within domain II and four epitopes within domain III. Additionally, we showed that VLPs displaying selected epitopes elicited antibodies that bound to native ZIKV envelope protein but failed to prevent infection in a mouse challenge model.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0042682223000016; http://dx.doi.org/10.1016/j.virol.2023.01.001; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85145852395&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/36623351; https://linkinghub.elsevier.com/retrieve/pii/S0042682223000016; https://dx.doi.org/10.1016/j.virol.2023.01.001
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know